CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Allscripts - MDRX CFD

    6.79
    10.19%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    Trading сonditions
    Spread 0.07
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026179 %
    Charges from full value of position ($-4.97)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026179%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.003957 %
    Charges from full value of position ($0.75)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.003957%
    Overnight fee time 21:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Veradigm Inc ESG Risk Ratings

    High Medium Low Negligible

    ‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 7.56
    Open* 7.12
    1-Year Change* -57.08%
    Day's Range* 6.22 - 7.25
    52 wk Range 8.68-18.81
    Average Volume (10 days) 2.15M
    Average Volume (3 months) 30.87M
    Market Cap 989.89M
    P/E Ratio 9.63
    Shares Outstanding 109.26M
    Revenue 837.19M
    EPS 0.94
    Dividend (Yield %) N/A
    Beta 0.72
    Next Earnings Date N/A

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Feb 28, 2024 6.79 -0.14 -2.02% 6.93 7.30 6.18
    Feb 27, 2024 7.56 0.68 9.88% 6.88 7.84 6.77
    Feb 26, 2024 8.27 0.02 0.24% 8.25 8.51 8.20
    Feb 23, 2024 8.24 0.00 0.00% 8.24 8.31 8.16
    Feb 22, 2024 8.34 0.21 2.58% 8.13 8.41 8.02
    Feb 21, 2024 8.25 -0.07 -0.84% 8.32 8.34 8.22
    Feb 20, 2024 8.34 0.28 3.47% 8.06 8.47 8.05
    Feb 16, 2024 8.23 -0.10 -1.20% 8.33 8.47 8.20
    Feb 15, 2024 8.49 0.42 5.20% 8.07 8.51 8.06
    Feb 14, 2024 8.02 -0.22 -2.67% 8.24 8.30 7.86
    Feb 13, 2024 8.23 -0.22 -2.60% 8.45 8.60 8.19
    Feb 12, 2024 8.60 0.15 1.78% 8.45 8.73 8.45
    Feb 9, 2024 8.51 0.27 3.28% 8.24 8.57 8.24
    Feb 8, 2024 8.48 0.13 1.56% 8.35 8.51 8.20
    Feb 7, 2024 8.35 -0.51 -5.76% 8.86 8.88 8.33
    Feb 6, 2024 8.93 -0.04 -0.45% 8.97 9.24 8.79
    Feb 5, 2024 9.07 0.16 1.80% 8.91 9.25 8.86
    Feb 2, 2024 8.98 -0.11 -1.21% 9.09 9.17 8.96
    Feb 1, 2024 9.16 0.07 0.77% 9.09 9.22 9.08
    Jan 31, 2024 9.10 -0.25 -2.67% 9.35 9.46 9.09

    Allscripts Events

    Time (UTC) Country Event
    No events scheduled
    View all events
    • Annual
    • Quarterly
    2021 2020 2019 2018 2017
    Total revenue 1503.04 1502.7 1632.61 1617.84 1497.71
    Revenue 1503.04 1502.7 1632.61 1617.84 1497.71
    Cost of Revenue, Total 883.472 937.005 1022.32 996.45 864.909
    Gross Profit 619.565 565.695 610.287 621.391 632.799
    Total Operating Expense 1417.47 1635.16 1732.95 1629.45 1650.51
    Selling/General/Admin. Expenses, Total 313.814 389.941 400.808 432.849 400.688
    Research & Development 193.671 206.061 245.443 258.736 202.282
    Depreciation / Amortization 23.109 25.604 27.188 26.558 17.345
    Unusual Expense (Income) 3.402 76.544 37.188 -85.139 165.29
    Operating Income 85.569 -132.455 -100.34 -11.613 -152.806
    Interest Income (Expense), Net Non-Operating -11.409 -16.91 -42.507 -50.655 -36.719
    Other, Net 87.666 0.054 -138.904 0.069 -0.512
    Net Income Before Taxes 161.826 -149.311 -281.751 -62.199 -190.037
    Net Income After Taxes 133.975 -132.619 -241.383 -43.216 -169.179
    Minority Interest 0 0 0.424 4.527 1.566
    Net Income Before Extra. Items 133.975 -132.619 -240.959 -38.689 -167.613
    Total Extraordinary Items 0.463 833.026 58.781 402.429 -28.846
    Net Income 134.438 700.407 -182.178 363.74 -196.459
    Income Available to Common Excl. Extra. Items 133.975 -132.619 -240.959 -38.689 -167.613
    Income Available to Common Incl. Extra. Items 134.438 700.407 -182.178 363.74 -196.459
    Diluted Net Income 134.438 700.407 -182.178 363.74 -196.459
    Diluted Weighted Average Shares 138.658 159.281 166.306 176.038 180.83
    Diluted EPS Excluding Extraordinary Items 0.96623 -0.83261 -1.44889 -0.21978 -0.92691
    Diluted Normalized EPS 0.98654 -0.52025 -1.30354 -0.53414 -0.33277
    Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021
    Total revenue 151.922 150.898 142.672 391.699 144.668
    Revenue 151.922 150.898 142.672 391.699 144.668
    Cost of Revenue, Total 68.486 71.416 69.191 222.706 75.028
    Gross Profit 83.436 79.482 73.481 168.993 69.64
    Total Operating Expense 126.921 156.254 136.1 350.312 117.821
    Selling/General/Admin. Expenses, Total 32.518 59.647 41.318 74.222 27.392
    Research & Development 23.681 22.75 23.42 47.739 21.042
    Depreciation / Amortization 2.236 2.241 2.171 5.643 2.363
    Operating Income 25.001 -5.356 6.572 41.387 26.847
    Interest Income (Expense), Net Non-Operating -1.863 -2.094 -2.534 -1.379 -3.874
    Other, Net 1.655 2.133 0.012 65.172 4.493
    Net Income Before Taxes 24.793 -5.317 4.05 105.18 27.466
    Net Income After Taxes 10.925 3.262 18.471 87.283 20.276
    Net Income Before Extra. Items 10.925 3.262 18.471 87.283 20.276
    Total Extraordinary Items 3.603 -67.288 4.386 -0.008 -4.096
    Net Income 14.528 -64.026 22.857 87.275 16.18
    Income Available to Common Excl. Extra. Items 10.925 3.262 18.471 87.283 20.276
    Income Available to Common Incl. Extra. Items 14.528 -64.026 22.857 87.275 16.18
    Diluted Net Income 14.528 -64.026 22.857 87.275 16.18
    Diluted Weighted Average Shares 110.206 114.251 138.685 128.389 123.892
    Diluted EPS Excluding Extraordinary Items 0.09913 0.02855 0.13319 0.67983 0.16366
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS 0.09913 0.02969 0.13319 0.67985 0.11597
    Unusual Expense (Income) 0 0.2 0.002 -8.004
    Minority Interest 0
    • Annual
    • Quarterly
    2021 2020 2019 2018 2017
    Total Current Assets 1554.5 1153.22 841.262 858.965 857.11
    Cash and Short Term Investments 132.517 531.104 129.668 174.243 119.47
    Cash & Equivalents 132.517 531.104 129.668 174.243 119.47
    Total Receivables, Net 235.051 479.493 555.733 531.715 492.56
    Accounts Receivable - Trade, Net 235.051 454.072 555.733 531.715 492.56
    Prepaid Expenses 60.511 136.264 147.99 142.193 105.319
    Other Current Assets, Total 1126.42 6.361 7.871 10.814 139.761
    Total Assets 2425.23 2917.62 3205.74 3181.48 4230.15
    Property/Plant/Equipment, Total - Net 28.143 168.763 186.359 121.913 135.417
    Property/Plant/Equipment, Total - Gross 492.736 506.71 401.116 380.694
    Accumulated Depreciation, Total -323.973 -320.351 -279.203 -245.277
    Goodwill, Net 506.607 974.729 1362.02 1373.74 1292.75
    Intangibles, Net 224.378 479.804 618.071 640.741 630.418
    Long Term Investments 12.26 10.744 11.332
    Other Long Term Assets, Total 71.169 86.674 119.139 114.242 1314.46
    Total Current Liabilities 597.988 934.777 1210.69 797.73 889.625
    Accounts Payable 5.281 35.905 104.014 73.166 85.749
    Accrued Expenses 91.706 203.456 326.855 179.777 146.677
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 0 364.547 21.055 28.789
    Other Current Liabilities, Total 501.001 695.416 415.274 523.732 628.41
    Total Liabilities 1017.09 1251.38 1920.55 1630.37 3109.27
    Total Long Term Debt 350.062 167.587 551.049 648.307 909.072
    Long Term Debt 350.062 167.587 551.004 647.539 906.725
    Capital Lease Obligations 0.045 0.768 2.347
    Deferred Income Tax 16.625 18.186 21.038 58.47 23.258
    Minority Interest 0 29.314 470.725
    Other Liabilities, Total 52.416 130.825 137.774 96.55 816.588
    Total Equity 1408.14 1666.24 1285.19 1551.11 1120.88
    Preferred Stock - Non Redeemable, Net 0 0 0 0 0
    Common Stock 2.766 2.745 2.725 2.709 2.693
    Additional Paid-In Capital 1962.39 1902.78 1907.35 1881.49 1781.06
    Retained Earnings (Accumulated Deficit) 767.556 633.118 -49.336 132.842 -338.15
    Treasury Stock - Common -1321.81 -870.558 -571.157 -460.543 -322.735
    Unrealized Gain (Loss) -4.392 -5.584 -2.676
    Other Equity, Total -2.765 -1.838 0 0.195 0.691
    Total Liabilities & Shareholders’ Equity 2425.23 2917.62 3205.74 3181.48 4230.15
    Total Common Shares Outstanding 116.114 139.942 162.475 171.224 180.831
    Note Receivable - Long Term 28.174 43.682 67.559 71.879 0
    Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021
    Total Current Assets 810.77 828.767 1540.68 1554.5 804.961
    Cash and Short Term Investments 492.597 500.164 82.782 132.517 214.179
    Cash & Equivalents 492.597 500.164 82.782 132.517 214.179
    Total Receivables, Net 234.482 215.775 225.659 235.051 464.168
    Accounts Receivable - Trade, Net 234.482 215.775 225.659 235.051 464.168
    Prepaid Expenses 74.384 91.521 56.191 60.511 124.473
    Other Current Assets, Total 9.307 21.307 1176.05 1126.42 2.141
    Total Assets 1690.66 1714.22 2430.25 2425.23 2484.31
    Property/Plant/Equipment, Total - Net 26.233 30.875 26.075 28.143 123.964
    Goodwill, Net 523.927 524.149 520.187 506.607 974.427
    Intangibles, Net 223.358 231.751 236.619 224.378 425.129
    Note Receivable - Long Term 27.957 19.358 19.198 28.174 51.119
    Other Long Term Assets, Total 66.361 67.737 75.63 71.169 104.706
    Total Current Liabilities 253.091 256.328 646.855 597.988 566.94
    Accounts Payable 12.609 18.014 15.548 5.281 21.801
    Accrued Expenses 122.94 123.06 85.828 91.706 205.547
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 117.542 115.254 545.479 501.001 339.592
    Total Liabilities 513.636 517.868 1077.15 1017.09 1065.72
    Total Long Term Debt 200.326 199.895 377.059 350.062 373.187
    Long Term Debt 200.326 199.895 377.059 350.062 373.187
    Deferred Income Tax 8.082 10.861 0 16.625 16.494
    Other Liabilities, Total 52.137 50.784 53.235 52.416 109.098
    Total Equity 1177.02 1196.35 1353.11 1408.14 1418.59
    Preferred Stock - Non Redeemable, Net 0 0 0 0 0
    Common Stock 2.794 2.79 2.776 2.766 2.766
    Additional Paid-In Capital 1923.56 1923.81 1922.03 1962.39 1952.1
    Retained Earnings (Accumulated Deficit) 753.392 738.864 802.89 767.556 680.281
    Treasury Stock - Common -1498.84 -1465.18 -1371.48 -1321.81 -1213.31
    Other Equity, Total -3.886 -3.934 -3.102 -2.765 -3.242
    Total Liabilities & Shareholders’ Equity 1690.66 1714.22 2430.25 2425.23 2484.31
    Total Common Shares Outstanding 109.26 110.792 114.792 116.114 122.57
    Long Term Investments 12.053 11.579 11.862 12.26
    • Annual
    • Quarterly
    2021 2020 2019 2018 2017
    Net income/Starting Line 133.975 -132.619 -182.602 407.807 -154.175
    Cash From Operating Activities -75.428 -106.715 46.254 67.891 247.911
    Cash From Operating Activities 176.137 192.269 207.106 192.346 157.328
    Deferred Taxes -2.099 -3.275 -37.97 4.144 -10.228
    Non-Cash Items -359.954 -10.842 78.081 -476.32 197.24
    Cash Taxes Paid 330.473 76.595 42.972 10.108 6.675
    Cash Interest Paid 4.993 24.616 19.604 28.888 21.183
    Changes in Working Capital -23.487 -152.248 -18.361 -60.086 57.746
    Cash From Investing Activities -12.175 1615.19 -161.056 248.013 -412.972
    Capital Expenditures -78.56 -105.018 -130.436 -144.617 -157
    Other Investing Cash Flow Items, Total 66.385 1720.21 -30.62 392.63 -255.972
    Cash From Financing Activities -258.866 -1109.76 67.343 -292.983 198.585
    Financing Cash Flow Items -16.423 -10.402 -92.993 128.123 23.515
    Issuance (Retirement) of Stock, Net -417.443 -334.863 -111.46 -137.645 -10.509
    Issuance (Retirement) of Debt, Net 175 -764.494 271.796 -283.461 185.579
    Foreign Exchange Effects -0.476 1.212 0.203 -0.624 0.86
    Net Change in Cash -346.945 399.926 -47.256 22.297 34.384
    Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021
    Net income/Starting Line 32.658 21.733 18.471 133.975 46.692
    Cash From Operating Activities 95.767 67.626 69.261 -75.428 -140.472
    Cash From Operating Activities 42.278 28.465 14.101 176.137 132.989
    Deferred Taxes -2.978 -0.467 -17.042 -2.099 -1.65
    Non-Cash Items -8.608 0.379 38.475 -359.954 -305.842
    Changes in Working Capital 32.417 17.516 15.256 -23.487 -12.661
    Cash From Investing Activities 603.719 612.973 -44.199 -12.175 -54.873
    Capital Expenditures -28.083 -19.91 -9.945 -78.56 -60.033
    Other Investing Cash Flow Items, Total 631.802 632.883 -34.254 66.385 5.16
    Cash From Financing Activities -387.374 -348.92 -62.966 -258.866 -125.32
    Financing Cash Flow Items -32.678 -27.883 -13.287 -16.423 -16.367
    Issuance (Retirement) of Stock, Net -177.031 -143.372 -49.679 -417.443 -308.953
    Issuance (Retirement) of Debt, Net -177.665 -177.665 0 175 200
    Foreign Exchange Effects -0.728 -0.728 -0.011 -0.476 -0.48
    Net Change in Cash 311.384 330.951 -37.915 -346.945 -321.145

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Allscripts Company profile

    About Allscripts Healthcare Solutions Inc

    Allscripts Healthcare Solutions, Inc. delivers information technology (IT) solutions and services to help healthcare organizations. The Company’s segments include the Hospitals and Large Physician Practices and the Veradigm. The Hospitals and Large Physician Practices reportable segment offers integrated clinical and financial management solutions, which primarily include (electronic health record) EHR-related software, related installation, support and maintenance, outsourcing and private cloud hosting. The Veradigm reportable segment offers payer and life sciences solutions, which are mainly targeted at payers, life sciences companies and other key healthcare stakeholders. The Veradigm also offers software applications for patient engagement and the sale of EHR software to single-specialty and small and mid-sized physician practices, including related clinical, financial, administrative and operational solutions.

    Financial summary

    BRIEF: For the fiscal year ended 31 December 2021, Allscripts Healthcare Solutions Inc revenues remained flat at $1.5B. Net income before extraordinary items totaled $134M vs. loss of $132.6M. Revenues reflect Data, Analytics and Care Coordination segment increase from $261.3M to $552.2M, Other international segment increase of 13% to $53.7M, Canada segment increase of 2% to $16M.

    Equity composition

    Common Stock $.01 Par, 03/11, 199M auth., 252,492,000 issd., less 61,308,000 shs. in Treas. @ $613K Insiders own 7.49%. IPO: 7/23/99, 7M shs @ $16 by Goldman, Sachs & Co. PO: 3/00, 2.4M shares (1,092,000 by the Co.) @ $73 by Goldman, Sachs. All Preferred stock converted into Common upon IPO. 8/10 Name chanhe from Allscripts-misys Healthcare Solutions

    Industry: Medical Software & Technology Services

    222 Merchandise Mart Plaza
    Suite 2024
    CHICAGO
    ILLINOIS 60654
    US

    Income Statement

    • Annual
    • Quarterly

    News

    We’re partnering with Newsquawk

    Filter out the noise and focus on the news that matters.

    08:32, 23 April 2024

    US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft

    The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.

    15:56, 22 April 2024

    Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported

    Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.

    07:56, 17 April 2024

    US Earnings Season : JP Morgan, Citigroup, Wells Fargo

    The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

    16:03, 11 April 2024

    Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

    The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

    09:22, 11 April 2024

    US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

    US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

    15:11, 9 April 2024

    How escalating geopolitical tensions are impacting oil markets

    The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.

    13:34, 4 April 2024

    People also watch

    ETH/USD

    3,275.46 Price
    +1.770% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 21:00 (UTC)
    Spread 6.00

    Gold

    2,326.96 Price
    +0.200% 1D Chg, %
    Long position overnight fee -0.0193%
    Short position overnight fee 0.0111%
    Overnight fee time 21:00 (UTC)
    Spread 0.40

    BTC/USD

    67,076.80 Price
    +0.980% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 21:00 (UTC)
    Spread 106.00

    US100

    17,592.10 Price
    +0.430% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 21:00 (UTC)
    Spread 1.8

    Still looking for a broker you can trust?

    Join the 610,000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading